Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP2C19 | P33261 | 6/20 | 0.49 |
| ▸ | CYP3A4 | P08684 | 4/20 | 0.47 |
| ▸ | BRAF | P15056 | 8/20 | 0.44 |
| ▸ | MAP2K4 | P45985 | 2/20 | 0.40 |
| ▸ | PAK1 | Q13153 | 2/20 | 0.40 |
| ▸ | BMPR1B | O00238 | 1/20 | 0.40 |
| ▸ | PLK4 | O00444 | 1/20 | 0.40 |
| ▸ | PIR | O00625 | 1/20 | 0.40 |
| ▸ | AURKA | O14965 | 1/20 | 0.40 |
| ▸ | DCLK1 | O15075 | 1/20 | 0.40 |
| ▸ | EPHB6 | O15197 | 1/20 | 0.40 |
| ▸ | RIPK2 | O43353 | 1/20 | 0.40 |
| ▸ | STK16 | O75716 | 1/20 | 0.40 |
| ▸ | OXSR1 | O95747 | 1/20 | 0.40 |
| ▸ | MAP4K4 | O95819 | 1/20 | 0.40 |
| ▸ | ABL1 | P00519 | 1/20 | 0.40 |
| ▸ | RAF1 | P04049 | 1/20 | 0.40 |
| ▸ | LCK | P06239 | 1/20 | 0.40 |
| ▸ | FYN | P06241 | 1/20 | 0.40 |
| ▸ | FES | P07332 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL298856 | 0.99 | CYP2C19 (0.49) | CYP2C19CYP3A4BRAFMAP2K4PAK1 | |
| SCHEMBL298381 | 0.85 | BRAF (0.44) | BRAFMAP2K4NEK2MAP2K1CYP2C9 | |
| SCHEMBL298667 | 0.85 | BRAF (0.52) | CYP2C19CYP3A4BRAFMAP2K4PAK1 | |
| SCHEMBL298226 | 0.85 | PAK1 (0.51) | CYP2C19CYP3A4BRAFPAK1 | |
| SCHEMBL298554 | 0.84 | BTK (0.45) | CYP2C19CYP3A4BRAFMAP2K4PAK1 | |
| SCHEMBL7874849 | 0.84 | BRAF (0.37) | CYP2C19CYP3A4BRAFMAP2K4PAK1 | |
| SCHEMBL298320 | 0.84 | CYP2C9 (0.48) | CYP2C19CYP3A4BRAFMAP2K4PAK1 | |
| SCHEMBL296369 | 0.84 | BRAF (0.44) | BRAFMAP2K4KDRNEK2MAP2K1 | |
| SCHEMBL299112 | 0.84 | CYP2C19 (0.67) | CYP2C19CYP3A4BRAFMAP2K4PAK1 | |
| SCHEMBL298881 | 0.84 | CAMKK2 (0.48) | CYP2C19CYP3A4BRAFMAP2K4PAK1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20120122860-A1 | SOLID FORMS OF SULFONAMIDES AND AMINO ACIDS | PLEXXIKON, INC. | 2012-05-17 | — | — | US | disclosed |
| US-20120122860-A1 | SOLID FORMS OF SULFONAMIDES AND AMINO ACIDS | PLEXXIKON, INC. | 2012-05-17 | — | — | US | disclosed |
| EP-2427433-A1 | SOLID FORMS OF SULFONAMIDES AND AMINO ACIDS | Plexxikon, Inc. (US) | 2012-03-14 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120122860-A1 | SOLID FORMS OF SULFONAMIDES AND AMINO ACIDS | BRAF, RAF1, ARAF | CYP2C19 2730/4885CYP3A4 3611/4885BRAF 1/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.